# NuBloom reviews (2026): GLP-1 telehealth sellers | This GLP Six dose strengths are listed on the product page and every one of them costs the same. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/nubloom Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Six doses, one price # NuBloom review Six dose strengths are listed on the product page and every one of them costs the same. ## The verdict NuBloom publishes $149 a month for compounded semaglutide, on a month-to-month subscription. Six dose strengths are listed at that figure. Coverage is 49 states. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection States 49 From From $149/mo Prescription Required Compounded Yes — not FDA-approved Availability 49 states NuBloom sells both molecules by injection. Doses of 0.25, 0.5, 1, 1.7, 2 and 2.4 mg are listed. A BMI of 27 or above is required. 1. ## Who writes the prescription, and what do they see? A prescription precedes shipping. The BMI threshold is published. The clinician is not described. Listing every dose beside one price answers the escalation question without a ladder. A reader can see the top of the range and what it costs. 2. ## What happens when the dose goes up? This is answered plainly. Six strengths run from 0.25 to 2.4 mg at the same monthly figure. Nothing describes clinical support at a step. 3. ## What the price includes Six months at $149 is $894 and that total holds at any listed dose. Tirzepatide is $249 on a microdose product page, which is a narrower plan than the semaglutide line. Both are month to month. 4. ## What it claims, and what it cites Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named. ## Where it holds up, and where it does not - Strength: Six dose strengths listed with one price - Strength: Coverage recorded across 49 states - Strength: Month to month on both lines - Strength: The BMI threshold is published - Limitation: The tirzepatide line is a microdose product - Limitation: One state is not served - Limitation: No compounding pharmacy is named ## What the evidence says about this kind of treatment The assessment above is about NuBloom. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who wants the top dose priced before starting the lowest. Wrong for A reader wanting a full-dose tirzepatide plan. ## The evidence behind what NuBloom prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How NuBloom compares | Seller | Who it suits | Go | | --- | --- | --- | | Nucore Health | A reader paying from an FSA or HSA who will ask to be quoted a real figure | | | Obu Health | Readers who value a site that agrees with itself | | | NuDay Rx | Readers wanting an oral semaglutide at the injection price | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Roboclinic](https://thisglp.com/reviews/roboclinic) [Roen Rx](https://thisglp.com/reviews/roen-rx) [RX Bella](https://thisglp.com/reviews/rx-bella) [Rx.com](https://thisglp.com/reviews/rx-com) [RxION Health](https://thisglp.com/reviews/rxion-health) [RxPepsDirect](https://thisglp.com/reviews/rxpepsdirect) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Does the price change by dose? No. Six strengths from 0.25 to 2.4 mg are listed at $149 a month. Is the tirzepatide line the same? No. It is a microdose product at $249 a month. Is there a BMI requirement? Yes. A BMI of 27 or above is stated. Is NuBloom legit? NuBloom is a GLP-1 telehealth sellers service. Its stated availability: 49 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay. Is NuBloom expensive compared with other GLP-1 telehealth sellers? NuBloom publishes a starting figure of $149/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts NuBloom below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).